Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Atrial fibrillation (AF) has been reported in up to 16% of patients taking ibrutinib. Data regarding the management of AF in this patient population are limited, and stroke prevention poses a challenge because of increased risk of bleeding with ibrutinib treatment. Our study sought to describe the i...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Blood Adv
Κύριοι συγγραφείς: Wiczer, Tracy E., Levine, Lauren B., Brumbaugh, Jessica, Coggins, Jessica, Zhao, Qiuhong, Ruppert, Amy S., Rogers, Kerry, McCoy, Anli, Mousa, Luay, Guha, Avirup, Heerema, Nyla A., Maddocks, Kami, Christian, Beth, Andritsos, Leslie A., Jaglowski, Samantha, Devine, Steven, Baiocchi, Robert, Woyach, Jennifer, Jones, Jeffrey, Grever, Michael, Blum, Kristie A., Byrd, John C., Awan, Farrukh T.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2017
Θέματα:
Lymphoid Neoplasia
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728342/
https://ncbi.nlm.nih.gov/pubmed/29296820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009720
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια